Search

Search Constraints

You searched for: Author/Creator Lawrence, Donald P.

Search Results

21. Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma. Issue 6 (December 2018)

22. Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum. Issue 5 (10th March 2020)

24. Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab. Issue 5 (10th February 2023)

25. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy‐Mediated Systemic Control. (22nd February 2019)

26. Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. (10th September 2019)